Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
Open AccessCase report

Multi-visceral resection of pancreatic VIPoma in a patient with sinistral portal hypertension

David L Joyce1 email, Kelvin Hong2 email, Elliot K Fishman3 email, Joshua Wisell4 email and Timothy M Pawlik1 email

1Departments of Surgery, Johns Hopkins School of Medicine, Baltimore, MD, 22187-6681, USA

2Department of Interventional Radiology, Johns Hopkins School of Medicine, Baltimore, MD, 22187-6681, USA

3Department of Radiology, Johns Hopkins School of Medicine, Baltimore, MD, 22187-6681, USA

4Department of Pathology, Johns Hopkins School of Medicine, Baltimore, MD, 22187-6681, USA

author email corresponding author email

World Journal of Surgical Oncology 2008, 6:80doi:10.1186/1477-7819-6-80

Published: 28 July 2008

Abstract

Background

VIPomas are rare neuroendocrine tumors poorly described in the literature. Aggressive resection of patients with advanced VIPoma neuroendocrine tumors has rarely been reported.

Case presentation

A 46 year old women presented with abdominal pain and diarrhea. A three-dimensional (3-D) pancreas protocol computed tomography scan revealed an 18 × 12 cm pancreatic VIPoma abutting the liver, stomach, spleen, left adrenal, colon that also invaded the distal duodenum – proximal jejunum at the ligament of Treitz in association with sinistral portal hypertension. Following preoperative proximal splenic artery embolization, the patient with underwent successful en bloc resection of the locally advanced VIPoma in conjunction with a diaphragmatic resection, total gastrectomy, splenectomy, left adrenalectomy, as well as small and large bowel resection. The estimated blood loss was 500 ml. All margins were negative (R0 resection). The patient is alive and disease-free.

Conclusion

This case illustrates the role of aggressive resection of pancreatic neuroendocrine tumors and highlights several key technical points that allowed for successful resection.


© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.